Groundhog Inc. (TPE:6906)

Theseus Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	343.01	856.25	494.13	297.43	354.08	242.51
Short-Term Investments	501.1	48.08	6.14	107.1	47.47	114.84
Cash & Short-Term Investments	844.11	904.33	500.27	404.53	401.55	357.35
Cash Growth	-6.97%	80.77%	23.67%	0.74%	12.37%	88.87%
Accounts Receivable	238.13	215.78	142.19	147.77	116.53	184.64
Receivables	238.13	215.78	142.19	147.77	116.53	184.64
Other Current Assets	52.36	6.07	4.58	18.35	14.68	17.78
Total Current Assets	1,135	1,126	647.04	570.64	532.76	559.77
Property, Plant & Equipment	8.37	11.4	23.58	33.91	46.3	56.64
Long-Term Investments	-	-	-	100	1.92	0.96
Long-Term Deferred Tax Assets	-	1.87	2.32	0.83	-2.36	-5.28
Other Long-Term Assets	5.36	3.04	3.23	3.36	8.47	14.51
Total Assets	1,148	1,142	676.16	708.75	587.08	626.6
Accounts Payable	1.07	1.06	0.99	0.95	0.22	0.24
Current Portion of Leases	6.27	8.94	10.54	9.46	10.17	9.08
Current Income Taxes Payable	41.63	37.52	27.56	25.51	9.56	17.13
Current Unearned Revenue	46.97	45.12	37.56	71.28	72.65	80.5
Other Current Liabilities	69.98	85.29	61.44	59.8	45.42	50.16
Total Current Liabilities	165.92	177.92	138.09	167	138.02	157.11
Long-Term Leases	-	-	8.94	19.48	28.93	39.1
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.29
Other Long-Term Liabilities	11.21	2.89	1.72	1.21	6.71	1.16
Total Liabilities	177.12	188.39	155.94	193.05	173.66	202.49
Common Stock	335.37	335.37	305.42	305.42	282.8	280
Additional Paid-In Capital	461.23	461.23	78.1	78.1	78.1	77.36
Retained Earnings	169.86	153.18	134.33	129.77	52.94	66.17
Comprehensive Income & Other	4.74	4.31	2.37	2.39	-0.42	0.58
Shareholders' Equity	971.2	954.09	520.23	515.69	413.42	424.11
Total Liabilities & Equity	1,148	1,142	676.16	708.75	587.08	626.6
Total Debt	6.27	8.94	19.48	28.93	39.1	48.18
Net Cash (Debt)	837.84	895.39	480.79	375.6	362.44	309.17
Net Cash Growth	-5.91%	86.23%	28.01%	3.63%	17.23%	65.01%
Net Cash Per Share	24.88	26.66	15.19	11.92	11.88	12.63
Filing Date Shares Outstanding	33.54	33.54	30.54	30.54	30.54	30.24
Total Common Shares Outstanding	33.54	33.54	30.54	30.54	30.54	30.24
Working Capital	968.68	948.26	508.94	403.64	394.74	402.66
Book Value Per Share	28.96	28.45	17.03	16.88	13.54	14.02
Tangible Book Value	971.2	954.09	520.23	515.69	413.42	424.11
Tangible Book Value Per Share	28.96	28.45	17.03	16.88	13.54	14.02
Machinery	5.84	5.66	7.39	6.46	6.48	4.59
Construction In Progress	-	0.18	-	-	-	-
Leasehold Improvements	9.27	9.27	9.27	9.27	9.27	9.27

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.